Saturday, June 18, 2022 7:59:58 PM
An adjunct use of Ifenprodil with chemo for SCLC and cancer tumors may also be 'chased'. AGN licensed the IP.
One trick pony? Speculative investment and always has been, IMO.
The endpoints for the CC/IPF study will at least enable something CC. Maybe in Australia as AGN/NASH have THAT door as a solid backstay.
Most of us have been here through a lot chasing Breath and COVID. We know the past. There were obvious chances and risks.
I am speculating on the possible positive future.
These are ALL possibly big deals, IMO. A sustainable pipeline?
The current cards could be played quick as Shell implies some might. (imo). Long ago I posted to push the BTH run with small buys ( at least) to enable a BLO type run.
With some Positive Results and thoughtful actions AGN may move quick AND sustainably. .. (insert Sly + Family Stone @ Woodstock).
...GLTA...
...
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM